Back to search

Sweden· SE-20120412000055

Ovaleap 900 IE/1,5 ml Injektionsvätska, lösning

A medicinal product containing follitropin alfa (genetical recombination), registered in Sweden by Theramex Ireland Limited.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedOvaleap 900 IE/1,5 ml Injektionsvätsk…ATC—REGISTER NO.SE-20120412000055PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Follitropin Alfa (Genetical Recombination)
Manufacturer
Theramex Ireland Limited
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20120412000055

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Follitropin alfa (genetical recombination) in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All follitropin alfa (genetical recombination) products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Bemfola, Gonal-F
  • Liechtenstein · Bemfola, Gonal-F
  • Norway · Bemfola, Gonal-F

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b023bb91-3269-4efd-8134-e4a138212359
GET /v1/drugs/b023bb91-3269-4efd-8134-e4a138212359?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20120412000055",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120412000055",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/ovaleap-epar-product-information_sv.pdf"
}

See everything about follitropin alfa (genetical recombination).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.